HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tian-Wen Li Selected Research

CCTA-1523

7/2017Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tian-Wen Li Research Topics

Disease

3Neoplasms (Cancer)
01/2023 - 03/2012
1Glioblastoma (Glioblastoma Multiforme)
01/2023
1Glioma (Gliomas)
01/2023

Drug/Important Bio-Agent (IBA)

1SurvivinIBA
01/2023
1Temozolomide (Temodar)FDA LinkGeneric
01/2023
1InterferonsIBA
01/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2017
1CCTA-1523IBA
07/2017
1Dichloroacetic AcidIBA
03/2012

Therapy/Procedure

1Therapeutics
01/2023